Scalable Life Sciences ondersteunt Bavarian Nordic op de terreinen market acces en public affairs.
Bavarian Nordic is an international biotechnology company
developing and manufacturing novel cancer
immunotherapies and vaccines for infectious diseases.
Bavarian Nordic focuses on developing product candidates to
address cancer and infectious diseases
by leveraging several core strengths: